title: Personality disorders improve in patients treated for major depression.
abstract: OBJECTIVE
  To examine the stability of personality disorders and their change in response to the treatment of major depression.
  
  
  METHODS
  149 depressed out-patients taking part in a treatment study were systematically assessed for personality disorders at baseline and after 18 months of treatment using the SCID-II.
  
  
  RESULTS
  Personality disorder diagnoses and symptoms demonstrated low-to-moderate stability (overall kappa = 0.41). In general, personality disorder diagnoses and symptoms significantly reduced over the 18 months of treatment. There was a trend for the patients who had a better response to treatment to lose more personality disorder symptoms, but even those who never recovered from their depression over the 18 months of treatment lost, on average, nearly three personality disorder symptoms.
  
  
  CONCLUSIONS
  Personality disorders are neither particularly stable nor treatment resistant. In depressed out-patients, personality disorder symptoms in general improve significantly even in patients whose response to their treatment for depressive symptoms is modest or poor.
authors.affiliation: Department of Psychological Medicine, University of Otago, Christchurch, Christchurch, New Zealand. roger.mulder@otago.ac.nz
authors.forename: Roger T
authors.initials: RT
authors.lastname: Mulder
authors.forename: P R
authors.initials: PR
authors.lastname: Joyce
authors.forename: C M A
authors.initials: CM
authors.lastname: Frampton
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology* / Q000523:psychology; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007406:Interview, Psychological; D008297:Male; D009661:Nortriptyline / Q000627:therapeutic use*; D010552:Personality Assessment; D010554:Personality Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology* / Q000523:psychology
chemical_list: D000928:Antidepressive Agents; D005473:Fluoxetine; D009661:Nortriptyline